comprehens
inform
small
molecul
biolog
activ
pubchem
databas
allow
chemoinformat
research
access
make
use
largescal
biolog
activ
data
improv
precis
drug
profil
quantit
structureact
relationship
approach
classif
use
predict
activeinact
compound
rel
overal
biolog
activ
antitumor
antibiot
activ
use
data
set
compound
pubchem
use
best
classif
model
antibiot
antitumor
activ
data
set
marin
microbi
natur
product
antimarin
databas
new
lead
compound
antibiot
antitumor
drug
design
propos
respect
compound
propos
approach
classifi
nonantibiot
nonantitumor
compound
antimarin
databas
recent
sever
leadlik
compound
propos
us
report
activ
literatur
small
organ
molecul
proven
import
tool
biolog
system
research
still
much
learn
use
structur
crc
dictionari
natur
product
np
approxim
least
one
biolog
test
result
describ
mdl
drug
data
report
databas
mddr
compil
prou
scienc
patent
literatur
sinc
np
synthet
product
inspir
np
singl
product
sourc
lead
develop
drug
fact
half
approv
drug
base
np
turn
centuri
new
branch
np
chemistri
fulli
establishedmarin
natur
product
mnp
fact
futur
seem
promis
new
branch
sinc
mnp
chemist
alreadi
elucid
chemic
structur
novel
compound
moreov
alreadi
approv
drug
four
anticanc
one
antivir
one
pain
control
one
hypertriglyceridemia
success
rate
drug
discoveri
marin
world
drug
per
natur
product
describ
rate
approxim
better
industri
averag
test
compound
nowaday
facil
highthroughput
screen
avail
academ
lab
drug
pharmaceut
compani
cost
random
screen
larg
collect
compound
nevertheless
prohibit
make
chemoinformat
approach
virtual
screen
probabl
activ
compound
valuabl
tool
although
last
year
chemoinformat
approach
appli
silico
screen
natur
product
field
significantli
improv
model
data
larg
databas
contain
inform
rel
biolog
activ
becom
avail
scientif
commun
besid
virtual
screen
comput
method
use
build
appropri
databas
allow
effect
shortcircuit
np
extract
derepl
procedur
certainli
result
increas
effici
drug
discoveri
exampl
power
databas
antimarin
contain
approxim
compound
marin
macroorgan
marin
terrestri
microorgan
antimarin
result
merger
antibas
databas
terrestri
marin
microbi
natur
product
marinlit
databas
marin
natur
product
literatur
bacteria
except
sourc
chemic
divers
among
speci
order
actinomycetal
commonli
call
actinomycet
singl
product
sourc
microbi
deriv
natur
product
account
ca
antibiot
discov
well
broad
rang
anticanc
agent
although
actinomycet
best
known
soil
bacteria
grow
interest
distribut
ecolog
role
marin
environ
observ
therefor
besid
marin
natur
product
mnp
refer
np
deriv
microbi
sourc
microbi
natur
product
b
np
account
terrestri
origin
work
explor
applic
machin
learn
ml
techniqu
exploit
leadlik
molecul
en
rout
antitumor
antibiot
drug
mnp
b
np
extract
antimarin
databas
model
develop
use
activ
nonact
compound
pubchem
databas
support
vector
machin
svm
random
forest
rf
classif
tree
ct
model
compar
predict
two
class
ie
activ
nonact
compound
follow
classif
task
overal
biolog
activ
antitumor
activ
antibiot
activ
cdk
descriptor
result
intern
valid
tenfold
crossvalid
svm
outofbag
estim
rf
train
set
extern
valid
test
set
present
tabl
test
set
test
set
ii
extract
antimarin
databas
also
use
main
purpos
extern
model
valid
antimarin
data
set
screen
develop
model
find
leadlik
molecul
en
rout
antitumor
antibiot
drug
inde
core
present
work
rf
show
better
perform
compar
singl
ct
svm
predict
overal
biolog
antitumor
antibiot
activ
test
set
take
account
valu
gmean
tabl
tenfold
crossvalid
b
outofbag
c
ratio
true
posit
sum
true
posit
fals
neg
ratio
true
neg
sum
true
neg
fals
posit
e
squar
root
product
sensit
specif
f
activ
g
nonact
expect
predict
power
ct
lower
obtain
two
ml
techniqu
three
activ
model
advantag
establish
simpl
rule
provid
insight
drug
profil
overal
biolog
activ
model
data
imbalanc
concern
activ
nonact
class
therefor
repres
problem
ct
method
abl
balanc
two
class
done
two
method
ie
adjust
weight
class
expect
overal
ct
biolog
model
show
poor
predict
accuracya
gmean
test
set
overal
biolog
activ
model
intend
improv
precis
leadlik
profil
compens
lack
bioactiv
record
compound
extract
antimarin
databas
like
databas
antimarin
databas
molecul
test
activ
chosen
research
grant
program
probabl
mani
bioactiv
molecul
lack
activ
record
never
test
biolog
screen
problem
mind
would
expect
difficulti
model
actual
fals
posit
fp
test
set
ii
inde
obtain
larg
number
fp
test
set
ii
shown
low
specif
valu
obtain
best
model
rf
compar
high
specif
valu
obtain
test
set
tabl
analysi
result
obtain
rf
svm
model
shown
fp
common
model
test
set
ii
respect
fp
obtain
averag
probabl
activ
probaveact
rf
model
fp
probaveact
fp
probaveact
test
set
ii
respect
mani
author
tri
ration
druglik
leadlik
natur
compound
waldmann
et
al
suggest
statist
analysi
structur
classif
natur
product
half
natur
product
right
size
serv
start
point
hit
lead
discoveri
leadlik
molecul
must
scaffold
two
three
four
ring
van
der
waal
volum
must
match
lower
end
major
protein
caviti
ie
van
der
waal
volum
analysi
activ
nonact
profil
van
der
waal
volum
compound
pubchem
train
set
test
set
compound
antimarin
test
set
ii
contain
differ
ring
number
demonstr
nonact
compound
antimarin
present
higher
number
compound
three
four
ring
right
size
pubchem
figur
fact
appear
correl
activ
compound
compound
van
der
waal
volum
test
set
compound
specif
compound
ie
approxim
activ
compar
activ
compound
ie
approxim
antimarin
test
set
ii
compound
specif
hand
compound
predict
true
posit
tp
probaveact
use
rf
model
test
set
ii
respect
moreov
test
set
ii
compound
predict
fp
compar
fp
test
set
probaveact
respect
addit
use
lipinski
ruleoff
analyz
rf
activ
model
wide
use
filter
drug
discoveri
evalu
drug
like
verifi
compound
activ
properti
would
make
possibl
oral
activ
drug
human
appli
optim
activ
select
druglik
properti
lead
compound
besid
wide
applic
emphas
realli
predict
compound
activ
lipinski
rule
state
compound
like
oral
activ
drug
easili
absorb
bodi
one
violat
follow
criteria
molecular
weight
less
estim
octanolwat
partit
coeffici
greater
sum
nitrogen
oxygen
atom
molecul
total
number
potenti
hydrogenbond
donor
criterion
appli
test
set
ii
filter
compound
conform
analyz
compar
rf
perform
set
filter
compound
similarli
rf
model
applic
test
set
ii
larg
number
fp
emerg
fp
rf
model
lipinski
fp
compound
well
compound
predict
fp
rf
model
probaveact
twenti
eight
mnp
scheme
list
probabl
activ
prob
activ
greater
equal
use
rf
activ
model
test
set
activ
compound
predict
prob
activ
greater
equal
use
rf
activ
model
propos
mnp
b
np
lead
bioactiv
compound
consid
misclassifi
nonact
compound
antimarin
databas
scheme
select
lead
bioactiv
mnp
b
np
antimarin
databas
use
therf
activ
model
fp
seven
compound
id
consid
fp
use
right
approach
one
id
conform
criteria
interestingli
fp
mnp
b
np
ie
b
np
mnp
classifi
antibiot
rf
antibiot
model
averag
probabl
antibiot
probaveantibiot
compar
mnp
b
np
ie
b
np
mnp
classifi
antitumor
rf
antitumor
model
averag
probabl
antitumor
probaveantitumor
fp
id
predict
antibiot
probabl
antibiot
prob
antibiot
greater
equal
use
rf
antibiot
model
although
biolog
activ
record
butirosin
analog
id
see
scheme
antimarin
databas
work
woo
et
al
shown
improv
antibiot
activ
deoxi
deriv
unit
name
id
butirosin
broadspectrum
aminoglycosid
antibiot
moreov
studi
refer
also
advantag
effect
function
unit
eg
id
compar
group
butirosin
b
np
id
organ
studi
deriv
arbekacin
id
see
scheme
identifi
resist
mani
inactiv
enzym
retain
intrins
antibiot
activ
unsubstitut
molecul
suscept
strain
far
know
bioactiv
deriv
id
see
scheme
gentamicin
natur
occur
broadspectrum
antibiot
never
record
howev
accord
literatur
expect
deriv
may
activ
sinc
carri
methyl
group
appear
respons
resist
nacetyltransferas
enzym
refer
gentamicin
aklavinon
glycosid
id
scheme
parent
aglycon
extens
famili
glycosid
deriv
anthracyclin
antibiot
possess
signific
anticanc
activ
although
specif
activ
b
np
yet
report
aglycon
luteolin
flavonoid
id
scheme
shown
inhibit
seri
human
cancer
cell
line
renal
ovari
melanoma
gastric
breast
human
leukemia
cell
recent
addit
antitumor
assay
suggest
could
interest
antitumor
np
even
activ
breast
adenocarcinoma
cell
aglycon
although
bioactiv
mnp
never
record
high
toxic
cortinarin
deriv
extens
report
best
antitumor
model
rf
model
obtain
larg
number
fp
well
fn
test
set
ii
shown
low
sensit
specif
valu
respect
valu
could
compar
sensit
specif
valu
obtain
test
set
respect
tabl
analysi
predict
obtain
test
set
ii
shown
tp
probaveantitumor
compar
probaveantitumor
obtain
fp
predict
opinion
fp
misclassif
antitumor
model
instead
high
probabl
antitumor
prob
antitumor
leadlik
antitumor
mnp
b
np
misclassifi
nonantitumor
compound
antimarin
databas
conclus
support
low
percentag
misclassif
fp
obtain
test
set
compound
prob
antitumor
greater
equal
use
rf
antitumor
model
scheme
list
fp
prob
antitumor
greater
equal
use
rf
antitumor
model
scheme
select
lead
antitumor
mnp
b
np
antimarin
databas
use
rf
antitumor
model
propos
mnp
lead
antitumor
compound
although
antitumor
activ
record
antimarin
databas
fp
mnp
other
b
np
howev
antitumor
activ
report
recent
almost
half
fp
obtain
name
see
scheme
benzodiazepin
deriv
id
human
lung
carcinoma
cell
indol
alkaloid
id
human
leukemia
hela
human
cervix
carcinoma
cell
phenazin
deriv
id
lightactiv
tumor
cytotox
compound
id
lxfl
human
lung
carcinoma
cell
oxathiazepin
deriv
id
potent
antitumor
polyketid
metabolit
id
human
lung
cancer
cell
oxim
deriv
id
sever
nci
human
tumor
cell
take
account
measur
similar
rf
antitumor
model
compound
train
set
compound
test
set
iith
maximum
proxim
prox
max
valu
train
test
set
ii
compoundsit
possibl
establish
follow
correl
antithrombot
indol
alkaloid
id
scheme
present
prox
max
antithrombot
antitumor
benzenemethanol
cid
train
set
see
scheme
antibiot
diketopiperazin
id
scheme
present
prox
max
one
stereoisom
report
antibiot
antitumor
cid
train
set
scheme
stereoisom
id
scheme
present
prox
max
racem
cid
train
set
scheme
report
antitumor
antifung
bromin
phenylpyrrol
deriv
id
scheme
relat
chlorin
pyrrolnitrin
antibiot
antifung
mnp
test
set
cid
see
scheme
recent
report
activ
screen
potenti
antitumor
activ
moreov
phenylpyrrol
deriv
ie
id
test
set
ii
cid
test
set
predict
antitumor
rf
model
prob
antitumor
respect
antiinflammatori
id
scheme
mnp
potent
inhibitor
enzymat
assay
chemic
structur
similar
vitamin
e
probabl
help
protect
damag
effect
free
radic
well
known
possibl
contribut
develop
chronic
diseas
cancer
despit
tryptanthrin
analog
id
scheme
report
possess
vivo
antitumor
activ
human
tumor
cell
line
breast
lung
central
nervou
system
predict
antitumor
rf
model
prob
antitumor
model
mnp
id
present
prox
max
analges
antitumor
cannabinoid
cid
train
set
scheme
cannabinoid
cid
report
possess
antimitogen
activ
human
melanoma
cell
respect
fn
analysi
predict
obtain
test
set
ii
shown
tn
probaveantitumor
compar
probaveantitumor
obtain
fn
predict
fn
b
np
predict
prob
antitumor
lower
interestingli
compound
id
belong
class
anthracyclin
antibiot
one
wide
use
class
antitumor
antibiot
fn
isol
actinomycet
bacteria
genu
streptomyc
best
antibiot
model
rf
model
yield
larg
number
fp
well
fn
test
set
ii
shown
low
sensit
specif
valu
obtain
respect
valu
could
compar
sensit
specif
valu
obtain
respect
test
set
tabl
analysi
predict
obtain
test
set
ii
shown
tp
probaveantibiot
compar
probaveantibiot
obtain
fp
predict
opinion
fp
misclassif
antibiot
model
instead
high
prob
antibiot
may
leadlik
antibiot
mnp
b
np
misclassifi
nonantibiot
compound
antimarin
databas
test
set
compound
prob
antibiot
greater
equal
predict
tp
rf
model
done
antitumor
biolog
overal
model
propos
fp
prob
antibiot
greater
equal
test
set
ii
lead
antibiot
compound
tabl
given
supplementari
inform
analysi
predict
obtain
test
set
ii
shown
fp
prob
antibiot
greater
equal
fp
fp
id
alreadi
analyz
overal
biolog
model
scheme
scheme
illustr
fp
prob
antibiot
greater
equal
yet
report
work
sever
cephalosporin
analog
appear
antimarin
databas
without
activ
record
classifi
activ
overal
activ
antibiot
model
indic
cephalosporin
core
structur
appear
relev
antibiot
activ
structur
could
seen
scheme
id
scheme
id
howev
surpris
outcom
sinc
penicillin
cephalosporin
well
known
antibiot
drug
earliest
antibiot
discov
penicillin
analog
also
classifi
fp
id
scheme
among
relev
type
antibiot
classifi
fp
model
aminoglycosid
id
anthracyclin
antibiot
id
three
guanidinyl
deriv
id
also
classifi
antibiot
although
lack
report
antibiot
activ
deriv
id
scheme
suggest
take
account
remark
activ
pyricularia
oryza
caus
agent
rice
blast
diseas
fact
sever
antibiot
eg
blasticidin
kasugmycin
bramycin
miharamycin
aabomycin
possess
activ
deriv
id
may
like
candid
herbicid
antimicrobi
compound
id
scheme
report
possess
lower
activ
nmethylglycin
analog
id
id
id
predict
antibiot
rf
antibiot
model
probabl
antibiot
respect
weak
antibacteri
activ
report
guanidinyl
aminoglycosid
id
although
appear
antimarin
databas
antimicrobi
activ
polycarvenosid
analog
macrolid
id
see
scheme
human
lethal
toxin
final
mnp
id
maridomycin
cid
see
scheme
present
similar
structur
proxim
valu
scheme
unreport
lead
antibiot
mnp
b
np
antimarin
databas
use
rf
antitumor
model
prob
antibiot
greater
equal
set
descriptor
select
cf
filter
develop
model
present
tabl
model
built
use
cpsa
charg
partial
surfac
area
topolog
constitut
molecular
descriptor
topopsatopolog
polar
surfac
areadescriptor
select
use
model
ten
relev
descriptor
found
rf
algorithm
use
build
rf
model
also
includ
almost
case
differ
type
descriptor
mention
meandecreaseaccuraci
paramet
mean
decreas
accuraci
import
consid
reliabl
meandecreasegini
paramet
mean
decreas
gini
coeffici
howev
expect
sever
descriptor
common
measur
model
overal
biolog
activ
antitumor
antibiot
activ
three
four
six
ten
respect
import
descriptor
overal
activ
model
take
account
meandecreaseaccuraci
measur
rf
model
predict
overal
biolog
activ
antitumor
antibiot
activ
possibl
correl
activ
type
descriptor
select
instanc
overal
biolog
activ
appear
relat
electron
molecular
descriptor
cpsa
bcut
whim
descriptor
seem
main
role
model
overal
activ
bcut
descriptor
encod
connect
inform
atom
properti
molecul
whim
descriptor
weight
holist
invari
molecular
descriptor
built
way
captur
relev
molecular
inform
respect
molecular
size
shape
symmetri
atom
distribut
antitumor
activ
appear
larg
relat
topolog
descriptor
addit
molecular
distanc
edg
descriptor
mde
evalu
molecular
distanc
edg
descriptor
carbon
nitrogen
oxygen
atom
seem
import
type
descriptor
model
antitumor
activ
mde
descriptor
ten
import
descriptor
molecular
distanc
edg
primari
secondari
oxygen
atom
khssssch
fragment
count
descriptor
encod
presenc
tertiari
carbon
group
three
singl
bond
descriptor
select
machin
learn
techniqu
ie
cf
filter
svm
two
measur
rf
ct
import
descriptor
meandecreaseaccuraci
paramet
rf
model
well
first
descriptor
select
build
antitumor
classif
tree
see
graphic
represent
first
two
rule
antitumor
tree
figur
use
first
rule
antitumor
tree
antitumor
compound
nonantitumor
compound
possibl
correctli
discrimin
antitumornonantitumor
compound
correspond
train
set
compound
correspond
test
set
train
test
set
antitumornonantitumor
compound
respect
result
even
impress
rule
appliedfrom
antitumor
compound
correctli
classifi
train
set
test
set
two
leadlik
antitumor
mnp
b
np
alreadi
propos
classifi
nonantitumor
id
rule
remark
perform
descriptor
discrimin
antitumor
nonantitumor
compound
never
report
howev
report
import
mde
descriptor
model
chemic
reactiv
paramet
plateletderiv
growth
factor
pdgfr
inhibitor
factor
xa
inhibitor
inhibitor
dihydrofol
reductas
dhfr
inhibitor
descriptor
known
codifi
molecular
size
take
account
oxygen
atom
also
character
polar
inspect
compound
belong
train
set
reveal
descriptor
provid
indic
presenc
oxygencontain
group
glycosyl
amid
lactam
ester
lacton
togeth
hydroxyl
carboxyl
acid
ether
function
group
exampl
aminoglycosid
antibiot
cid
train
set
see
scheme
high
descriptor
valu
mannosylparomomycin
train
set
turn
antibiot
activ
seem
relat
mainli
topolog
constitut
descriptor
six
descriptor
select
machin
learn
techniqueson
electron
topopsa
two
topolog
distanc
edg
secondari
carbon
atom
two
constitut
khssssch
khsdssca
fragment
count
descriptor
codifi
presenc
quaternari
carbon
group
two
singl
bond
one
doubl
bond
one
molecular
number
secondari
carbon
atom
topopsa
import
descriptor
meandecreasegini
paramet
rf
model
well
first
descriptor
select
build
antibiot
tree
see
graphic
represent
antibiot
tree
first
rule
figur
use
first
rule
antibiot
tree
topopsa
antibiot
compound
topopsa
nonantibiot
compound
possibl
correctli
discrimin
antibioticnonantibiot
compound
train
set
test
set
respect
subsequ
topopsa
descriptor
present
similar
result
antibiot
nonantibiot
class
differ
antitumor
ct
model
descriptor
show
impress
discrimin
abil
rel
antitumor
compound
global
compound
correctli
classifi
rule
antibiot
compound
nonantibiot
compound
correctli
classifi
train
set
similar
result
obtain
test
set
three
b
np
leadlik
antibiot
mnp
b
np
alreadi
propos
classifi
nonantibiot
id
rule
spite
predict
power
topopsa
descriptor
model
antibiot
activ
never
report
import
predict
pglycoprotein
cytochrom
inhibitor
alreadi
notic
moreov
high
correl
descriptor
passiv
drug
transport
membran
drug
transport
multidrug
resist
associ
protein
also
report
train
test
set
extract
pubchem
databas
search
type
biolog
activ
eg
antitumor
antibiot
antimicrobi
antifung
antimalari
antihiv
chemic
structur
save
smile
data
format
train
test
set
compris
follow
biolog
categori
compound
antitumor
antibiot
antifung
antimalari
one
antihiv
antimicrobi
cytotox
nonact
import
refer
compound
one
bioactiv
record
nonact
compound
select
basi
least
screen
one
biolog
activ
whole
data
set
compound
divid
train
set
compound
test
set
compound
use
develop
extern
valid
qsar
classif
model
approxim
partit
carri
randomli
accord
antitumor
antibiot
nonact
categori
way
set
span
biolog
divers
data
set
test
set
test
set
ii
compris
mnp
b
np
extract
antimarin
databas
chemic
structur
mnp
download
mdl
sdf
format
drug
molecul
pubchem
origin
natur
sourc
origin
overlap
two
databas
assembl
two
databas
duplic
remov
although
chiral
taken
account
racem
compound
case
stereochemistri
indic
consid
one
possibl
stereoisom
smile
string
three
differ
data
set
natur
sourc
compound
test
set
ii
correspond
experiment
predict
activ
avail
supplementari
inform
molecular
structur
standard
normal
tautomer
group
remov
small
disconnect
fragment
use
jchem
standard
tool
version
chemaxon
ltd
budapest
hungari
threedimension
model
molecular
structur
gener
corina
version
molecular
network
gmbh
erlangen
germani
empir
molecular
descriptor
calcul
use
cdk
descriptor
calcul
total
descriptor
calcul
includ
electron
topolog
geometr
constitut
hybrid
bcut
whim
descriptor
remov
constant
descriptor
multilinear
regress
mlr
built
weka
select
descriptor
method
use
train
set
accord
preliminari
work
descriptor
select
cdk
collect
quest
qsar
classif
model
minimum
possibl
number
descriptor
featur
select
perform
cf
correlationbas
featur
subset
select
algorithm
implement
weka
heurist
take
account
use
individu
descriptor
predict
activitiy
ie
overal
biolog
antitumor
antibiot
togeth
level
intercorrel
among
experi
compar
descriptor
one
three
model
conduct
attributeselectedclassifi
routin
weka
cfssubsetev
option
descriptor
evalu
bestfirst
greedystepwis
option
search
method
procedur
select
descriptor
cf
algorithm
within
tenfold
crossvalid
procedur
k
nearest
neighbor
knn
algorithm
ml
techniqu
knn
algorithm
predict
activ
compound
major
vote
k
similar
compound
train
set
exampl
k
two
three
similar
compound
rel
queri
compound
activ
queri
molecul
classifi
activ
appli
weka
softwar
use
k
similar
neighbor
queri
compound
euclidean
distanc
measur
similar
contribut
neighbor
weight
invers
distanc
ct
grown
use
r
program
version
use
rpart
librari
implement
cart
algorithm
default
paramet
classif
tree
sequenti
construct
partit
compound
parent
node
two
child
node
node
produc
logic
rule
usual
defin
singl
descriptor
object
certain
descriptor
valu
fall
one
two
child
node
object
fall
child
node
predict
compound
reach
given
termin
node
obtain
major
vote
object
train
set
reach
termin
node
ct
model
built
use
cdk
descriptor
rf
ensembl
unprun
classif
tree
creat
use
bootstrap
sampl
train
data
best
split
node
defin
among
randomli
select
subset
descriptor
predict
made
major
vote
classif
tree
forest
addit
perform
intern
assess
predict
error
object
left
outin
bootstrap
procedur
intern
crossvalid
oob
estim
method
quantifi
import
descriptor
increas
misclassif
occur
valu
descriptor
randomli
permut
correl
mean
decreas
accuraci
paramet
decreas
node
impur
everi
time
descriptor
use
split
correl
mean
decreas
gini
coeffici
paramet
rf
also
assign
probabl
everi
predict
basi
number
vote
obtain
predict
class
measur
similar
two
object
calcul
number
tree
ensembl
classifi
two
object
termin
node
rf
grown
r
program
version
use
random
forest
librari
rf
model
built
tree
use
set
cdk
descriptor
result
natur
twoclass
imbal
overal
activ
model
problem
allevi
set
class
weight
svm
map
data
hyperspac
nonlinear
map
boundari
hyperplan
separ
two
class
compound
space
boundari
posit
use
exampl
train
set
known
support
vector
nonlinear
data
kernel
function
use
transform
hyperspac
class
becom
linearli
separ
studi
svm
establish
weka
program
use
libsvm
packag
type
svm
set
csvmclassif
kernel
function
radial
basi
function
paramet
c
csvmclassif
optim
rang
default
paramet
kernel
function
use
descriptor
select
cf
procedur
normal
use
develop
classif
model
activ
nonact
class
overal
activ
model
set
weight
respect
result
suggest
implement
computeraid
approach
could
use
predict
bioactiv
new
exist
np
without
bioactiv
record
way
identifi
propos
lead
compound
en
rout
specifi
activ
result
applic
approach
reduct
great
extent
number
compound
use
real
screen
obtain
result
present
screen
possibl
lead
compound
en
rout
antitumor
antibiot
drug
also
extern
support
public
literatur
activ
compound
compound
propos
initi
classifi
antimarin
databas
nonact
compound
without
activ
record
higher
level
accuraci
expect
larger
data
set
molecul
use
train
model
use
level
descriptor
better
encod
main
aspect
found
relev
classif
present
work
could
also
use
improv
classif
abil
model
interest
approach
futur
work
